Boc-L-Glutamic Acid CAS 2419-94-5 (Boc-Glu-OH) Purity >98.0% (HPLC) Factory
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of Boc-L-Glutamic Acid (Boc-Glu-OH) (CAS: 2419-94-5) with high quality. Ruifu Chemical supplys a series of amino acids and derivatives. We can provide worldwide delivery, small and bulk quantities available. Purchase Boc-Glu-OH, Please contact: alvin@ruifuchem.com
Chemical Name | Boc-L-Glutamic Acid |
Synonyms | Boc-Glu-OH; Boc-L-Glu-OH; N-Boc-L-Glutamic Acid; N-(tert-Butoxycarbonyl)-L-Glutamic Acid |
Stock Status | In Stock, Production Capacity 30 Tons per Month |
CAS Number | 2419-94-5 |
Molecular Formula | C10H17NO6 |
Molecular Weight | 247.25 g/mol |
Melting Point | 112.0~114.0℃ |
Density | 1.264 |
Water Solubility | Soluble in Water |
Storage Temp. | Cool & Dry Place (0~8℃) |
COA & MSDS | Available |
Category | Boc-Amino Acids |
Brand | Ruifu Chemical |
Items | Inspection Standards | Results |
Appearance | White Powder | White Powder |
Melting Point | 112.0~114.0℃ | 112.0~114.0℃ |
Specific Rotation [α]20/D | -16.5° to -12.5° (C=1 in MeOH) |
-13.7° |
Loss on Drying | <0.50% | 0.26% |
Purity / Analysis Method | >98.0% (HPLC) | 98.5% |
TLC Analysis | One Spot | Complies |
IR Spectrum | In Accordance With the Standard | Complies |
Mass Spectrum | In Accordance With the Standard | Complies |
NMR Spectrum | In Accordance With the Standard | Complies |
Conclusion | This Product by Inspection Accords with the Enterprise Standard | |
Main Uses | Boc-Amino Acids; Peptide Synthesis; Pharmaceutical Intermediates |
Package: Fluorinated Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool, dry (0~8℃) warehouse away from incompatible substances. Protect from light and moisture.
How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Hazard Symbols Xn - Harmful
Risk Codes
R20/21/22 - Harmful by inhalation, in contact with skin and if swallowed.
R36/37/38 - Irritating to eyes, respiratory system and skin.
Safety Description
S22 - Do not breathe dust.
S24/25 - Avoid contact with skin and eyes.
S36 - Wear suitable protective clothing.
S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
WGK Germany 3
HS Code 2922491990
Boc-L-Glutamic Acid (Boc-Glu-OH) (CAS: 2419-94-5) is an N-Boc-protected form of L-Glutamic Acid. L-Glutamic Acid is a nonessential amino acid that is important to the mammalian central nervous system. Amino acids and derivatives, peptide synthesis, organic synthesis intermediate, pharmaceutical intermediates, biochemical reagents. Boc-Glu-OH can be used as a pharmaceutical intermediate of Lenalidomide. In December 2005, the US Food and Drug Administration (FDA) approved lenalidomide to be used in the treatment of myelodysplastic syndrome (MDS).